Literature DB >> 1171519

Humoral immune system activity in inflammatory bowel disease.

P Teisberg, E Gjone.   

Abstract

In vivo activation of complement components C3 and GBG as revealed by crossed immunoelectrophoresis reflects humoral immune system activity in disease. These methods have been applied to a material of 25 patients with ulcerative colitis (UC) and 29 patients with Crohn's disease (CD). Signs of activity in the complement sequence were observed in approximately half the patients of both categories. Fifty blood samples from 30 healthy controls were all negative. The presence of complement activation was correlated with disease activity in both groups, and in patients with CD this could also be shown in longitudinal studies in single patients. In UC complement activation was correlated with the extent of the disease process. The serum levels of factors C4, GBG, and C3 in the patient groups did not differ significantly from those found in the normals.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1171519

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  16 in total

1.  Surface epithelium related activation of complement differs in Crohn's disease and ulcerative colitis.

Authors:  T S Halstensen; T E Mollnes; P Garred; O Fausa; P Brandtzaeg
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

2.  C3 metabolism in ulcerative colitis and Crohn's disease.

Authors:  H J Hodgson; B J Potter; D P Jewell
Journal:  Clin Exp Immunol       Date:  1977-06       Impact factor: 4.330

3.  Immune complexes in ulcerative colitis and Crohn's disease.

Authors:  H J Hodgson; B J Potter; D P Jewell
Journal:  Clin Exp Immunol       Date:  1977-08       Impact factor: 4.330

4.  Circulating immune complexes in ulcerative colitis. I. Correlation to disease activity.

Authors:  H Nielsen; V Binder; H Daugharty; S E Svehag
Journal:  Clin Exp Immunol       Date:  1978-01       Impact factor: 4.330

5.  Defective release of C5a related chemo-attractant activity from complement in Crohn's disease.

Authors:  J Elmgreen; A Berkowicz; H Sørensen
Journal:  Gut       Date:  1983-06       Impact factor: 23.059

6.  Circulating immune complexes in Crohn's disease. Their characterization and interrelationship with components of the complement system.

Authors:  E R Richens; C M Thorp; P W Bland; N D Hall
Journal:  Dig Dis Sci       Date:  1982-02       Impact factor: 3.199

7.  Complement inhibitors and immunoconglutinins in ulcerative colitis and Crohn's disease.

Authors:  B J Potter; D J Brown; A Watson; D P Jewell
Journal:  Gut       Date:  1980-12       Impact factor: 23.059

8.  Leucocyte function in ulcerative colitis. Quantitative leucocyte mobilisation to skin windows and in vitro function of blood leucocytes.

Authors:  J H Wandall; V Binder
Journal:  Gut       Date:  1982-09       Impact factor: 23.059

9.  Leucocyte function in Crohn's disease. Studies on mobilisation using a quantitative skin window technique and on the function of circulating polymorphonuclear leucocytes in vitro.

Authors:  J H Wandall; V Binder
Journal:  Gut       Date:  1982-03       Impact factor: 23.059

10.  Complement studies in children with treated coeliac disease after gluten challenge.

Authors:  C Bosch; M Becker; H W Rotthauwe; W Opferkuch
Journal:  Eur J Pediatr       Date:  1980-08       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.